Literature DB >> 2487682

Effects of the deregulated expression of human interleukin-2 in transgenic mice.

Y Ishida1, M Nishi, O Taguchi, K Inaba, N Minato, M Kawaichi, T Honjo.   

Abstract

We constructed transgenic mice that carry the cDNA of human interleukin-2 (IL-2) under the control of the H-2Kd promoter. The IL-2 transgenic mice expressed human IL-2 mRNA in the thymus, spleen, bone marrow, lung, muscle and skin. Human IL-2 protein was also detected in their sera. The IL-2 transgenic mice suffered from alopecia and pneumonia, but no typical autoimmune reactions seemed to be involved in these lesions. In the epidermis of the IL-2 transgenic mice there was an increase in Thy-1+ dendritic epidermal cells (DEC), which might be involved in the skin lesion. Immune responses of their spleen cells against antigens were significantly impaired whereas their spleen cells responded well to polyclonal lymphocyte activators.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2487682     DOI: 10.1093/intimm/1.2.113

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  14 in total

1.  The effect of neonatal tolerance to bovine gamma globulin (BGG) on BGG-reactive CD4+ T lymphocytes.

Authors:  S S Burtles; D C Hooper
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

Review 2.  Animal models for the biological effects of continuous high cytokine levels.

Authors:  M Lübbert; D Jonas; F Herrmann
Journal:  Blut       Date:  1990-11

Review 3.  Transgenic mice in the study of cytokine function.

Authors:  J Taverne
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

4.  NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human.

Authors:  Jianhua Yu; Takeki Mitsui; Min Wei; Hsiaoyin Mao; Jonathan P Butchar; Mithun Vinod Shah; Jianying Zhang; Anjali Mishra; Christopher Alvarez-Breckenridge; Xingluo Liu; Shujun Liu; Akihiko Yokohama; Rossana Trotta; Guido Marcucci; Don M Benson; Thomas P Loughran; Susheela Tridandapani; Michael A Caligiuri
Journal:  J Clin Invest       Date:  2011-04       Impact factor: 14.808

5.  IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice.

Authors:  J Marks-Konczalik; S Dubois; J M Losi; H Sabzevari; N Yamada; L Feigenbaum; T A Waldmann; Y Tagaya
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

6.  Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA.

Authors:  T Yamaoka; C Nishimura; K Yamashita; M Itakura; T Yamada; J Fujimoto; Y Kokai
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

7.  Lymphocyte infiltration of the skin in transgenic mice carrying the human interleukin-2 gene.

Authors:  M Akiyama; M Yokoyama; M Katsuki; S Habu; T Nishikawa
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

Review 8.  Transgenic mice and squamous multistage skin carcinogenesis.

Authors:  K Brown; A Balmain
Journal:  Cancer Metastasis Rev       Date:  1995-06       Impact factor: 9.264

9.  Interleukin-6 expands homeostatic space for peripheral T cells.

Authors:  Changwan Hong; Anna S Nam; Hilary R Keller; Davinna L Ligons; Joo-Young Park; Hee-Won Yoon; Joseph J Park; Megan A Luckey; Jung-Hyun Park
Journal:  Cytokine       Date:  2013-08-26       Impact factor: 3.861

Review 10.  Analysis of the immune system with transgenic mice: B cell development and lymphokines.

Authors:  A Iglesias
Journal:  Experientia       Date:  1991-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.